245 related articles for article (PubMed ID: 7684192)
21. A comparative analysis of nuclear DNA content and N-myc gene amplification in neuroblastoma.
Taylor SR; Locker J
Cancer; 1990 Mar; 65(6):1360-6. PubMed ID: 2306684
[TBL] [Abstract][Full Text] [Related]
22. Identification of MYCN gene amplification in neuroblastoma using chromogenic in situ hybridization (CISH): an alternative and practical method.
Bhargava R; Oppenheimer O; Gerald W; Jhanwar SC; Chen B
Diagn Mol Pathol; 2005 Jun; 14(2):72-6. PubMed ID: 15905689
[TBL] [Abstract][Full Text] [Related]
23. Amplification of c-myc, K-sam, and c-met in gastric cancers: detection by fluorescence in situ hybridization.
Hara T; Ooi A; Kobayashi M; Mai M; Yanagihara K; Nakanishi I
Lab Invest; 1998 Sep; 78(9):1143-53. PubMed ID: 9759658
[TBL] [Abstract][Full Text] [Related]
24. Heterogeneity of MYCN amplification in a child with stroma-rich neuroblastoma (ganglioneuroblastoma).
Lorenzana AN; Zielenska M; Thorner P; Gerrie B; Weitzman S; Squire J
Pediatr Pathol Lab Med; 1997; 17(6):875-83. PubMed ID: 9353827
[TBL] [Abstract][Full Text] [Related]
25. Human neuroblastoma cell lines that express N-myc without gene amplification.
Wada RK; Seeger RC; Brodeur GM; Einhorn PA; Rayner SA; Tomayko MM; Reynolds CP
Cancer; 1993 Dec; 72(11):3346-54. PubMed ID: 8242562
[TBL] [Abstract][Full Text] [Related]
26. Deletion mapping in neuroblastoma cell lines suggests two distinct tumor suppressor genes in the 1p35-36 region, only one of which is associated with N-myc amplification.
Cheng NC; Van Roy N; Chan A; Beitsma M; Westerveld A; Speleman F; Versteeg R
Oncogene; 1995 Jan; 10(2):291-7. PubMed ID: 7838528
[TBL] [Abstract][Full Text] [Related]
27. The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2.
Godfried MB; Veenstra M; v Sluis P; Boon K; v Asperen R; Hermus MC; v Schaik BD; Voûte TP; Schwab M; Versteeg R; Caron HN
Oncogene; 2002 Mar; 21(13):2097-101. PubMed ID: 11960382
[TBL] [Abstract][Full Text] [Related]
28. Rapid and accurate determination of MYCN copy number and 1p deletion in neuroblastoma by quantitative PCR.
Anderson J; Gibson S; Williamson D; Rampling D; Austin C; Shipley J; Sebire N; Brock P
Pediatr Blood Cancer; 2006 Jun; 46(7):820-4. PubMed ID: 16220551
[TBL] [Abstract][Full Text] [Related]
29. Morphologic and molecular cytogenetics in neuroblastoma.
Avet-Loiseau H; Venuat AM; Benard J; Leibovitch MP; Hartmann O; Bernheim A
Cancer; 1995 Apr; 75(7):1694-9. PubMed ID: 8826929
[TBL] [Abstract][Full Text] [Related]
30. Expression of neuronal src mRNA as a favorable marker and inverse correlation to N-myc gene amplification in human neuroblastomas.
Matsunaga T; Shirasawa H; Tanabe M; Ohnuma N; Kawamura K; Etoh T; Takahashi H; Simizu B
Int J Cancer; 1994 Sep; 58(6):793-8. PubMed ID: 7523310
[TBL] [Abstract][Full Text] [Related]
31. Detection of amplified N-myc gene in neuroblastoma by in situ hybridization using the single-step silver enhancement method.
Noguchi M; Hirohashi S; Tsuda H; Nakajima T; Hara F; Shimosato Y
Mod Pathol; 1988 Nov; 1(6):428-32. PubMed ID: 3222254
[TBL] [Abstract][Full Text] [Related]
32. Evolution of unbalanced gain of distal chromosome 2p in neuroblastoma.
Stallings RL; Carty P; McArdle L; Mullarkey M; McDermott M; O'Meara A; Ryan E; Catchpoole D; Breatnach F
Cytogenet Genome Res; 2004; 106(1):49-54. PubMed ID: 15218241
[TBL] [Abstract][Full Text] [Related]
33. Autoregulation of the human N-myc oncogene is disrupted in amplified but not single-copy neuroblastoma cell lines.
Sivak LE; Tai KF; Smith RS; Dillon PA; Brodeur GM; Carroll WL
Oncogene; 1997 Oct; 15(16):1937-46. PubMed ID: 9365240
[TBL] [Abstract][Full Text] [Related]
34. Investigation of co-amplification of the candidate genes ornithine decarboxylase, ribonucleotide reductase, syndecan-1 and a DEAD box gene, DDX1, with N-myc in neuroblastoma. United Kingdom Children's Cancer Study Group.
George RE; Kenyon RM; McGuckin AG; Malcolm AJ; Pearson AD; Lunec J
Oncogene; 1996 Apr; 12(7):1583-7. PubMed ID: 8622876
[TBL] [Abstract][Full Text] [Related]
35. [Molecular genetic abnormalities of N-myc and C-myc in pediatric neuroblastic tumors and clinical pathologic significance].
Cai RQ; Zhou CJ; Sun QN; Ma XL; Wang M; Li Y; Wang DY; Gong LP
Zhonghua Bing Li Xue Za Zhi; 2013 May; 42(5):299-304. PubMed ID: 24004585
[TBL] [Abstract][Full Text] [Related]
36. Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma.
Caron H; van Sluis P; de Kraker J; Bökkerink J; Egeler M; Laureys G; Slater R; Westerveld A; Voûte PA; Versteeg R
N Engl J Med; 1996 Jan; 334(4):225-30. PubMed ID: 8531999
[TBL] [Abstract][Full Text] [Related]
37. Automatic quantification of gene amplification in clinical samples by IQ-FISH.
Narath R; Lörch T; Rudas M; Ambros PF
Cytometry B Clin Cytom; 2004 Jan; 57(1):15-22. PubMed ID: 14696059
[TBL] [Abstract][Full Text] [Related]
38. Correlation between the number of segmental chromosome aberrations and the age at diagnosis of diploid neuroblastomas without MYCN amplification.
Souzaki R; Tajiri T; Teshiba R; Kinoshita Y; Yosue R; Kohashi K; Oda Y; Taguchi T
J Pediatr Surg; 2011 Dec; 46(12):2228-32. PubMed ID: 22152855
[TBL] [Abstract][Full Text] [Related]
39. Preferential amplification of the paternal allele in neuroblastomas with N-myc amplification.
Cheng JM; Hiemstra JL; Schneider SS; Kaufman BA; Naumova A; Cheung NK; Cohn SL; Diller L; Sapienza C; Brodeur GM
Prog Clin Biol Res; 1994; 385():43-9. PubMed ID: 7972236
[TBL] [Abstract][Full Text] [Related]
40. N-myc amplification in multiple homogeneously staining regions in two human neuroblastomas.
Emanuel BS; Balaban G; Boyd JP; Grossman A; Negishi M; Parmiter A; Glick MC
Proc Natl Acad Sci U S A; 1985 Jun; 82(11):3736-40. PubMed ID: 2582423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]